Steven Cooper Heard, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9007 Ellerbe Rd., Shreveport, LA 71106 Phone: 318-222-3278 Fax: 318-424-3155 |
David Cooksey, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1455 E Bert Kouns Loop, Shreveport, LA 71105 Phone: 318-798-4677 Fax: 318-798-4417 |
Mrs. Anne B Bryan, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9007 Ellerbe Rd, Shreveport, LA 71106 Phone: 318-222-3278 Fax: 318-424-3155 |
Mr. David J Clemons, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 845 Olive St, Shreveport, LA 71104 Phone: 318-222-3278 Fax: 318-421-3155 |
Mr. Donald I Posner, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 845 Olive St, Shreveport, LA 71104 Phone: 318-222-3278 Fax: 318-421-3155 |
Dr. Laura Sherrod Haynie, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2751 Albert L Bicknell Dr, Suite 2-d, Shreveport, LA 71103 Phone: 318-221-2623 Fax: 318-424-9850 |
Dr. Patrick Richard Carrington, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1501 Kings Hwy, Shreveport, LA 71103 Phone: 318-675-5000 |
Dr. Jason Jude Romero, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 845 Olive St, Shreveport, LA 71104 Phone: 318-222-3278 Fax: 318-424-3155 |
Mr. Jack S Resneck, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 845 Olive St, Shreveport, LA 71104 Phone: 318-222-3278 Fax: 318-424-3155 |
News Archive
A new study led by researchers at Harvard Medical School and the Harvard T.H. Chan School of Public Health has identified some of the first known inherited genetic variants that significantly raise a person's likelihood of developing clonal hematopoiesis, an age-related white blood cell condition linked with higher risk of certain blood cancers and cardiovascular disease.
Patients with rheumatoid arthritis are at increased risk of a surprise heart attack, according to new research presented today at ICNC 12 by Dr Adriana Puente, a cardiologist in the National Medical Centre "20 de Noviembre" ISSSTE in Mexico City, Mexico.
Standard guidelines for stroke treatment currently recommend clot removal only within six hours of stroke onset. But a milestone study with results published today in the New England Journal of Medicine shows that clot removal up to 24 hours after stroke led to significantly reduced disability for properly selected patients.
VolitionRx Limited, a life sciences company focused on developing diagnostic tests for cancer and other conditions, today announced that the University Hospital Bonn in Germany will initiate a clinical confirmatory study to assess VolitionRx's proprietary Nucleosomics platform technology for the diagnosis of lung cancer through a blood test in individuals.
By the beginning of the month, 4.2 million people had selected a plan. But that doesn't mean they have insurance. Reporters on a conference call asked about the number who had paid, and the administration's representatives said they don't know.
› Verified 8 days ago